PMC:7261349 / 7182-8222 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid_Glycan-Motif-Structure

    {"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T45","span":{"begin":312,"end":319},"obj":"https://glytoucan.org/Structures/Glycans/G00021MO"},{"id":"T46","span":{"begin":312,"end":319},"obj":"https://glytoucan.org/Structures/Glycans/G54161DR"}],"text":"N Age M(SD) Female n(%) Death n(%)\nTotal cohort 2075 67.57 (15.52) 819 (39.47%) 301 (14.51%)\nOxygen saturation \u003c 90% Yes 70 73.18 (13.7) 20 (28.57) 28 (53.85)\nNo 221 67.00 (16.14) 95 (42.99) 24 (46.15)\nTemperature \u003e 37° C Yes 159 61.20 (17.27) 47 (29.56) 24 (10.86)\nNo 1422 68.53 (15.65) 577 (40.58) 197 (89.14)\nHeparin Yes 1734 68.77 (15.09) 686 (39.56) 242 (13.96)\nNo 285 61.76 (17.67) 96 (33.68) 44 (15.44)\nHydroxychloroquine Yes 1857 67.11 (15.51) 705 (37.96) 237 (12.76)\nNo 162 73.47 (16.22) 77 (47.53) 49 (30.25)\nAzithromycin Yes 1223 68.33 (15.03) 456 (37.29) 146 (11.94)\nNo 796 66.54 (16.51) 326 (40.95) 140 (17.59)\nSteroids Yes 960 69.88 (16.76) 330 (34.38) 200 (20.83)\nNo 1059 65.58 (16.76) 452 (42.68) 86 (8.12)\nTocilizumab Yes 421 66.1 (13.11) 117 (27.79) 89 (21.14)\nNo 1598 68.00 (16.24) 665 (41.61) 197 (12.33)\nLopinavir + Ritonavir Yes 1230 63.94 (14.28) 421 (34.23) 160 (13.01)\nNo 789 73.37 (15.99) 361 (45.75) 126 (15.97)\nOseltamivir Yes 132 67.78 (13.79) 51 (38.64) 26 (19.70)\nNo 1887 67.61 (15.78) 731 (38.74) 260 (13.78)"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"227","span":{"begin":312,"end":319},"obj":"Chemical"},{"id":"228","span":{"begin":825,"end":846},"obj":"Chemical"},{"id":"229","span":{"begin":24,"end":29},"obj":"Disease"}],"attributes":[{"id":"A227","pred":"tao:has_database_id","subj":"227","obj":"MESH:D006493"},{"id":"A228","pred":"tao:has_database_id","subj":"228","obj":"MESH:C558899"},{"id":"A229","pred":"tao:has_database_id","subj":"229","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"N Age M(SD) Female n(%) Death n(%)\nTotal cohort 2075 67.57 (15.52) 819 (39.47%) 301 (14.51%)\nOxygen saturation \u003c 90% Yes 70 73.18 (13.7) 20 (28.57) 28 (53.85)\nNo 221 67.00 (16.14) 95 (42.99) 24 (46.15)\nTemperature \u003e 37° C Yes 159 61.20 (17.27) 47 (29.56) 24 (10.86)\nNo 1422 68.53 (15.65) 577 (40.58) 197 (89.14)\nHeparin Yes 1734 68.77 (15.09) 686 (39.56) 242 (13.96)\nNo 285 61.76 (17.67) 96 (33.68) 44 (15.44)\nHydroxychloroquine Yes 1857 67.11 (15.51) 705 (37.96) 237 (12.76)\nNo 162 73.47 (16.22) 77 (47.53) 49 (30.25)\nAzithromycin Yes 1223 68.33 (15.03) 456 (37.29) 146 (11.94)\nNo 796 66.54 (16.51) 326 (40.95) 140 (17.59)\nSteroids Yes 960 69.88 (16.76) 330 (34.38) 200 (20.83)\nNo 1059 65.58 (16.76) 452 (42.68) 86 (8.12)\nTocilizumab Yes 421 66.1 (13.11) 117 (27.79) 89 (21.14)\nNo 1598 68.00 (16.24) 665 (41.61) 197 (12.33)\nLopinavir + Ritonavir Yes 1230 63.94 (14.28) 421 (34.23) 160 (13.01)\nNo 789 73.37 (15.99) 361 (45.75) 126 (15.97)\nOseltamivir Yes 132 67.78 (13.79) 51 (38.64) 26 (19.70)\nNo 1887 67.61 (15.78) 731 (38.74) 260 (13.78)"}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T29","span":{"begin":312,"end":319},"obj":"Body_part"}],"attributes":[{"id":"A29","pred":"fma_id","subj":"T29","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"N Age M(SD) Female n(%) Death n(%)\nTotal cohort 2075 67.57 (15.52) 819 (39.47%) 301 (14.51%)\nOxygen saturation \u003c 90% Yes 70 73.18 (13.7) 20 (28.57) 28 (53.85)\nNo 221 67.00 (16.14) 95 (42.99) 24 (46.15)\nTemperature \u003e 37° C Yes 159 61.20 (17.27) 47 (29.56) 24 (10.86)\nNo 1422 68.53 (15.65) 577 (40.58) 197 (89.14)\nHeparin Yes 1734 68.77 (15.09) 686 (39.56) 242 (13.96)\nNo 285 61.76 (17.67) 96 (33.68) 44 (15.44)\nHydroxychloroquine Yes 1857 67.11 (15.51) 705 (37.96) 237 (12.76)\nNo 162 73.47 (16.22) 77 (47.53) 49 (30.25)\nAzithromycin Yes 1223 68.33 (15.03) 456 (37.29) 146 (11.94)\nNo 796 66.54 (16.51) 326 (40.95) 140 (17.59)\nSteroids Yes 960 69.88 (16.76) 330 (34.38) 200 (20.83)\nNo 1059 65.58 (16.76) 452 (42.68) 86 (8.12)\nTocilizumab Yes 421 66.1 (13.11) 117 (27.79) 89 (21.14)\nNo 1598 68.00 (16.24) 665 (41.61) 197 (12.33)\nLopinavir + Ritonavir Yes 1230 63.94 (14.28) 421 (34.23) 160 (13.01)\nNo 789 73.37 (15.99) 361 (45.75) 126 (15.97)\nOseltamivir Yes 132 67.78 (13.79) 51 (38.64) 26 (19.70)\nNo 1887 67.61 (15.78) 731 (38.74) 260 (13.78)"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T19","span":{"begin":12,"end":18},"obj":"http://purl.obolibrary.org/obo/UBERON_0003100"},{"id":"T20","span":{"begin":479,"end":482},"obj":"http://purl.obolibrary.org/obo/CLO_0001002"},{"id":"T21","span":{"begin":955,"end":958},"obj":"http://purl.obolibrary.org/obo/CLO_0054061"},{"id":"T22","span":{"begin":1017,"end":1020},"obj":"http://purl.obolibrary.org/obo/CLO_0001471"}],"text":"N Age M(SD) Female n(%) Death n(%)\nTotal cohort 2075 67.57 (15.52) 819 (39.47%) 301 (14.51%)\nOxygen saturation \u003c 90% Yes 70 73.18 (13.7) 20 (28.57) 28 (53.85)\nNo 221 67.00 (16.14) 95 (42.99) 24 (46.15)\nTemperature \u003e 37° C Yes 159 61.20 (17.27) 47 (29.56) 24 (10.86)\nNo 1422 68.53 (15.65) 577 (40.58) 197 (89.14)\nHeparin Yes 1734 68.77 (15.09) 686 (39.56) 242 (13.96)\nNo 285 61.76 (17.67) 96 (33.68) 44 (15.44)\nHydroxychloroquine Yes 1857 67.11 (15.51) 705 (37.96) 237 (12.76)\nNo 162 73.47 (16.22) 77 (47.53) 49 (30.25)\nAzithromycin Yes 1223 68.33 (15.03) 456 (37.29) 146 (11.94)\nNo 796 66.54 (16.51) 326 (40.95) 140 (17.59)\nSteroids Yes 960 69.88 (16.76) 330 (34.38) 200 (20.83)\nNo 1059 65.58 (16.76) 452 (42.68) 86 (8.12)\nTocilizumab Yes 421 66.1 (13.11) 117 (27.79) 89 (21.14)\nNo 1598 68.00 (16.24) 665 (41.61) 197 (12.33)\nLopinavir + Ritonavir Yes 1230 63.94 (14.28) 421 (34.23) 160 (13.01)\nNo 789 73.37 (15.99) 361 (45.75) 126 (15.97)\nOseltamivir Yes 132 67.78 (13.79) 51 (38.64) 26 (19.70)\nNo 1887 67.61 (15.78) 731 (38.74) 260 (13.78)"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T53","span":{"begin":8,"end":10},"obj":"Chemical"},{"id":"T54","span":{"begin":93,"end":99},"obj":"Chemical"},{"id":"T55","span":{"begin":312,"end":319},"obj":"Chemical"},{"id":"T56","span":{"begin":825,"end":834},"obj":"Chemical"},{"id":"T57","span":{"begin":939,"end":950},"obj":"Chemical"}],"attributes":[{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_74807"},{"id":"A54","pred":"chebi_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/CHEBI_15379"},{"id":"A55","pred":"chebi_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"},{"id":"A56","pred":"chebi_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A57","pred":"chebi_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"}],"text":"N Age M(SD) Female n(%) Death n(%)\nTotal cohort 2075 67.57 (15.52) 819 (39.47%) 301 (14.51%)\nOxygen saturation \u003c 90% Yes 70 73.18 (13.7) 20 (28.57) 28 (53.85)\nNo 221 67.00 (16.14) 95 (42.99) 24 (46.15)\nTemperature \u003e 37° C Yes 159 61.20 (17.27) 47 (29.56) 24 (10.86)\nNo 1422 68.53 (15.65) 577 (40.58) 197 (89.14)\nHeparin Yes 1734 68.77 (15.09) 686 (39.56) 242 (13.96)\nNo 285 61.76 (17.67) 96 (33.68) 44 (15.44)\nHydroxychloroquine Yes 1857 67.11 (15.51) 705 (37.96) 237 (12.76)\nNo 162 73.47 (16.22) 77 (47.53) 49 (30.25)\nAzithromycin Yes 1223 68.33 (15.03) 456 (37.29) 146 (11.94)\nNo 796 66.54 (16.51) 326 (40.95) 140 (17.59)\nSteroids Yes 960 69.88 (16.76) 330 (34.38) 200 (20.83)\nNo 1059 65.58 (16.76) 452 (42.68) 86 (8.12)\nTocilizumab Yes 421 66.1 (13.11) 117 (27.79) 89 (21.14)\nNo 1598 68.00 (16.24) 665 (41.61) 197 (12.33)\nLopinavir + Ritonavir Yes 1230 63.94 (14.28) 421 (34.23) 160 (13.01)\nNo 789 73.37 (15.99) 361 (45.75) 126 (15.97)\nOseltamivir Yes 132 67.78 (13.79) 51 (38.64) 26 (19.70)\nNo 1887 67.61 (15.78) 731 (38.74) 260 (13.78)"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T61","span":{"begin":0,"end":34},"obj":"Sentence"},{"id":"T62","span":{"begin":35,"end":92},"obj":"Sentence"},{"id":"T63","span":{"begin":93,"end":158},"obj":"Sentence"},{"id":"T64","span":{"begin":159,"end":201},"obj":"Sentence"},{"id":"T65","span":{"begin":202,"end":265},"obj":"Sentence"},{"id":"T66","span":{"begin":266,"end":311},"obj":"Sentence"},{"id":"T67","span":{"begin":312,"end":366},"obj":"Sentence"},{"id":"T68","span":{"begin":367,"end":409},"obj":"Sentence"},{"id":"T69","span":{"begin":410,"end":475},"obj":"Sentence"},{"id":"T70","span":{"begin":476,"end":518},"obj":"Sentence"},{"id":"T71","span":{"begin":519,"end":578},"obj":"Sentence"},{"id":"T72","span":{"begin":579,"end":623},"obj":"Sentence"},{"id":"T73","span":{"begin":624,"end":678},"obj":"Sentence"},{"id":"T74","span":{"begin":679,"end":722},"obj":"Sentence"},{"id":"T75","span":{"begin":723,"end":778},"obj":"Sentence"},{"id":"T76","span":{"begin":779,"end":824},"obj":"Sentence"},{"id":"T77","span":{"begin":825,"end":893},"obj":"Sentence"},{"id":"T78","span":{"begin":894,"end":938},"obj":"Sentence"},{"id":"T79","span":{"begin":939,"end":994},"obj":"Sentence"},{"id":"T80","span":{"begin":995,"end":1040},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"N Age M(SD) Female n(%) Death n(%)\nTotal cohort 2075 67.57 (15.52) 819 (39.47%) 301 (14.51%)\nOxygen saturation \u003c 90% Yes 70 73.18 (13.7) 20 (28.57) 28 (53.85)\nNo 221 67.00 (16.14) 95 (42.99) 24 (46.15)\nTemperature \u003e 37° C Yes 159 61.20 (17.27) 47 (29.56) 24 (10.86)\nNo 1422 68.53 (15.65) 577 (40.58) 197 (89.14)\nHeparin Yes 1734 68.77 (15.09) 686 (39.56) 242 (13.96)\nNo 285 61.76 (17.67) 96 (33.68) 44 (15.44)\nHydroxychloroquine Yes 1857 67.11 (15.51) 705 (37.96) 237 (12.76)\nNo 162 73.47 (16.22) 77 (47.53) 49 (30.25)\nAzithromycin Yes 1223 68.33 (15.03) 456 (37.29) 146 (11.94)\nNo 796 66.54 (16.51) 326 (40.95) 140 (17.59)\nSteroids Yes 960 69.88 (16.76) 330 (34.38) 200 (20.83)\nNo 1059 65.58 (16.76) 452 (42.68) 86 (8.12)\nTocilizumab Yes 421 66.1 (13.11) 117 (27.79) 89 (21.14)\nNo 1598 68.00 (16.24) 665 (41.61) 197 (12.33)\nLopinavir + Ritonavir Yes 1230 63.94 (14.28) 421 (34.23) 160 (13.01)\nNo 789 73.37 (15.99) 361 (45.75) 126 (15.97)\nOseltamivir Yes 132 67.78 (13.79) 51 (38.64) 26 (19.70)\nNo 1887 67.61 (15.78) 731 (38.74) 260 (13.78)"}